Search results
Bird flu tests are hard to get. How will we know when to sound the alarm?
NBC News via Yahoo News· 21 hours agoThe CDC has asked farmworkers with flu symptoms to get tested, but researchers are concerned about a...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab | CNN
CNN.com· 15 hours agoOn Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse...
Clinical trial shows 15-day Paxlovid regimen safe but adds no clear benefit for long COVID
Medical Xpress· 4 days agoIn a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day...
Newswise Expert | Jonathan Marron, Dana-Farber Cancer Institute
Newswise· 7 days agoHe completed his residency in Pediatrics at Stanford University and his fellowship in Clinical Medical Ethics at the University of ...Dana-Farber Cancer ...
Lilly's donanemab sails through FDA meeting with 2 unanimous votes in favor
FierceBiotech· 21 hours agoDo the available data show that donanemab is effective for the treatment of Alzheimer’s disease in...
Newswise Expert | Priya Jayachandran, Keck Medicine of USC
Newswise· 2 days agoDr. Jayachandran specializes in Breast Medical Oncology. She is an Assistant Professor of Clinical Medicine at Keck and also serves as the Director of
UChicago joins multisite study to improve health o | Newswise
Newswise· 7 days agoThe University of Chicago is among five clinical sites conducting a first-of-its-kind study aimed at uncovering risk factors and targeted interventions to better prevent disease ...
Dr. Chester W. ‘Chet’ Schmidt Jr., a founder of Chesapeake Physicians, dies
Baltimore Sun via Yahoo News· 5 days agoDr. Chester W. “Chet” Schmidt Jr., former chief of psychiatry at what is now Johns Hopkins Bayview Medical Center and a founder of Chesapeake Physicians, died May 15 of complications ...
The Roles of Rhizospheric and Endophytic Microorga | Newswise
Newswise· 5 days agoMedicinal plants are important economic crops and of great value in healthcare industry. Secondary...
Donanemab for Alzheimer's Gets Thumbs Up From FDA Panel
Medscape· 2 days agoAn 11-member advisory panel to the US Food and Drug Administration (FDA) has unanimously concluded...